Modis Navnirman Ltd: Intrinsic Value & Share Price Analysis

Share Price and Basic Stock Data

Last Updated: August 20, 2025, 8:39 pm

Quick Insight

Modis Navnirman Ltd, a player in the construction, contracting, and engineering sector, currently trades at a price of 275 with a market capitalization of 539 Cr. The company's P/E ratio stands at 44.0, indicating a premium valuation, while the ROE and ROCE figures at 12.9% and 16.7% respectively, reflect decent profitability. With a healthy operating profit margin of 19% and a net profit of 12 Cr, Modis Navnirman Ltd shows operational strength. However, the high P/BV ratio of 5.06x suggests the stock might be overvalued relative to its book value. Additionally, the company's CCC of 746 days warrants attention, indicating a potentially inefficient cash conversion cycle. Investors should closely monitor these metrics to gauge the company's financial health and performance moving forward.

Competitors of Modis Navnirman Ltd

All Competitor Stocks of Modis Navnirman Ltd

Quarterly Result

Last Updated: May 31, 2025, 5:32 am

Below is a detailed analysis of the quarterly data for Modis Navnirman Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Sales, as of Mar 2025, the value is 50.00 Cr.. The value appears strong and on an upward trend. It has increased from 37.00 Cr. (Sep 2024) to 50.00 Cr., marking an increase of 13.00 Cr..
• For Expenses, as of Mar 2025, the value is 40.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 31.00 Cr. (Sep 2024) to 40.00 Cr., marking an increase of 9.00 Cr..
• For Operating Profit, as of Mar 2025, the value is 9.00 Cr.. The value appears strong and on an upward trend. It has increased from 5.00 Cr. (Sep 2024) to 9.00 Cr., marking an increase of 4.00 Cr..
• For OPM %, as of Mar 2025, the value is 19.00%. The value appears strong and on an upward trend. It has increased from 14.00% (Sep 2024) to 19.00%, marking an increase of 5.00%.
• For Other Income, as of Mar 2025, the value is 1.00 Cr.. The value remains steady. There is no change compared to the previous period (Sep 2024) which recorded 1.00 Cr..
• For Interest, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Sep 2024) which recorded 0.00 Cr..
• For Depreciation, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Sep 2024) which recorded 0.00 Cr..
• For Profit before tax, as of Mar 2025, the value is 10.00 Cr.. The value appears strong and on an upward trend. It has increased from 6.00 Cr. (Sep 2024) to 10.00 Cr., marking an increase of 4.00 Cr..
• For Tax %, as of Mar 2025, the value is 26.00%. The value appears to be increasing, which may not be favorable. It has increased from 25.00% (Sep 2024) to 26.00%, marking an increase of 1.00%.
• For Net Profit, as of Mar 2025, the value is 8.00 Cr.. The value appears strong and on an upward trend. It has increased from 5.00 Cr. (Sep 2024) to 8.00 Cr., marking an increase of 3.00 Cr..
• For EPS in Rs, as of Mar 2025, the value is 3.95. The value appears strong and on an upward trend. It has increased from 2.32 (Sep 2024) to 3.95, marking an increase of 1.63.

Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.

Profit & Loss - Annual Report

Last Updated: July 15, 2025, 3:02 am

Growth

Last Updated: Unknown

Balance Sheet

Last Updated: July 25, 2025, 1:00 pm

Below is a detailed analysis of the balance sheet data for Modis Navnirman Ltd based on the most recent figures (Mar 2025) and their trends compared to the previous period:

• For Equity Capital, as of Mar 2025, the value is 19.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 19.00 Cr..
• For Reserves, as of Mar 2025, the value is 86.00 Cr.. The value appears strong and on an upward trend. It has increased from 66.00 Cr. (Mar 2024) to 86.00 Cr., marking an increase of 20.00 Cr..
• For Borrowings, as of Mar 2025, the value is 3.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 6.00 Cr. (Mar 2024) to 3.00 Cr., marking a decrease of 3.00 Cr..
• For Other Liabilities, as of Mar 2025, the value is 51.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 21.00 Cr. (Mar 2024) to 51.00 Cr., marking an increase of 30.00 Cr..
• For Total Liabilities, as of Mar 2025, the value is 159.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 113.00 Cr. (Mar 2024) to 159.00 Cr., marking an increase of 46.00 Cr..
• For Fixed Assets, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
• For CWIP, as of Mar 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2024) which recorded 0.00 Cr..
• For Investments, as of Mar 2025, the value is 5.00 Cr.. The value appears to be declining and may need further review. It has decreased from 15.00 Cr. (Mar 2024) to 5.00 Cr., marking a decrease of 10.00 Cr..
• For Other Assets, as of Mar 2025, the value is 154.00 Cr.. The value appears strong and on an upward trend. It has increased from 98.00 Cr. (Mar 2024) to 154.00 Cr., marking an increase of 56.00 Cr..
• For Total Assets, as of Mar 2025, the value is 159.00 Cr.. The value appears strong and on an upward trend. It has increased from 113.00 Cr. (Mar 2024) to 159.00 Cr., marking an increase of 46.00 Cr..

Notably, the Reserves (86.00 Cr.) exceed the Borrowings (3.00 Cr.), indicating a solid financial buffer.

Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.

Cash Flow

Free Cash Flow

Financial Efficiency Indicators

Share Holding Pattern

Key Financial Ratios

After reviewing the key financial ratios for Modis Navnirman Ltd, here is a detailed analysis based on the latest available data and recent trends:

• For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
• For Basic EPS (Rs.), as of Mar 25, the value is 6.42. This value is within the healthy range. It has increased from 3.48 (Mar 24) to 6.42, marking an increase of 2.94.
• For Diluted EPS (Rs.), as of Mar 25, the value is 6.42. This value is within the healthy range. It has increased from 3.48 (Mar 24) to 6.42, marking an increase of 2.94.
• For Cash EPS (Rs.), as of Mar 25, the value is 6.42. This value is within the healthy range. It has increased from 3.49 (Mar 24) to 6.42, marking an increase of 2.93.
• For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 55.31. It has increased from 44.48 (Mar 24) to 55.31, marking an increase of 10.83.
• For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 55.31. It has increased from 44.48 (Mar 24) to 55.31, marking an increase of 10.83.
• For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 45.33. It has increased from 30.07 (Mar 24) to 45.33, marking an increase of 15.26.
• For PBDIT / Share (Rs.), as of Mar 25, the value is 8.77. This value is within the healthy range. It has increased from 4.74 (Mar 24) to 8.77, marking an increase of 4.03.
• For PBIT / Share (Rs.), as of Mar 25, the value is 8.77. This value is within the healthy range. It has increased from 4.74 (Mar 24) to 8.77, marking an increase of 4.03.
• For PBT / Share (Rs.), as of Mar 25, the value is 8.64. This value is within the healthy range. It has increased from 4.72 (Mar 24) to 8.64, marking an increase of 3.92.
• For Net Profit / Share (Rs.), as of Mar 25, the value is 6.42. This value is within the healthy range. It has increased from 3.48 (Mar 24) to 6.42, marking an increase of 2.94.
• For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 6.42. This value is within the healthy range. It has increased from 3.48 (Mar 24) to 6.42, marking an increase of 2.94.
• For PBDIT Margin (%), as of Mar 25, the value is 19.35. This value is within the healthy range. It has increased from 15.76 (Mar 24) to 19.35, marking an increase of 3.59.
• For PBIT Margin (%), as of Mar 25, the value is 19.34. This value is within the healthy range. It has increased from 15.75 (Mar 24) to 19.34, marking an increase of 3.59.
• For PBT Margin (%), as of Mar 25, the value is 19.05. This value is within the healthy range. It has increased from 15.68 (Mar 24) to 19.05, marking an increase of 3.37.
• For Net Profit Margin (%), as of Mar 25, the value is 14.15. This value exceeds the healthy maximum of 10. It has increased from 11.58 (Mar 24) to 14.15, marking an increase of 2.57.
• For NP After MI And SOA Margin (%), as of Mar 25, the value is 14.15. This value is within the healthy range. It has increased from 11.58 (Mar 24) to 14.15, marking an increase of 2.57.
• For Return on Networth / Equity (%), as of Mar 25, the value is 11.60. This value is below the healthy minimum of 15. It has increased from 7.82 (Mar 24) to 11.60, marking an increase of 3.78.
• For Return on Capital Employeed (%), as of Mar 25, the value is 15.36. This value is within the healthy range. It has increased from 9.97 (Mar 24) to 15.36, marking an increase of 5.39.
• For Return On Assets (%), as of Mar 25, the value is 7.69. This value is within the healthy range. It has increased from 5.93 (Mar 24) to 7.69, marking an increase of 1.76.
• For Long Term Debt / Equity (X), as of Mar 25, the value is 0.03. This value is below the healthy minimum of 0.2. It has decreased from 0.06 (Mar 24) to 0.03, marking a decrease of 0.03.
• For Total Debt / Equity (X), as of Mar 25, the value is 0.03. This value is within the healthy range. It has decreased from 0.06 (Mar 24) to 0.03, marking a decrease of 0.03.
• For Asset Turnover Ratio (%), as of Mar 25, the value is 0.63. It has decreased from 0.67 (Mar 24) to 0.63, marking a decrease of 0.04.
• For Current Ratio (X), as of Mar 25, the value is 3.04. This value exceeds the healthy maximum of 3. It has decreased from 4.48 (Mar 24) to 3.04, marking a decrease of 1.44.
• For Quick Ratio (X), as of Mar 25, the value is 0.12. This value is below the healthy minimum of 1. It has decreased from 0.58 (Mar 24) to 0.12, marking a decrease of 0.46.
• For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 25.28 (Mar 24) to 0.00, marking a decrease of 25.28.
• For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 20. It has decreased from 25.25 (Mar 24) to 0.00, marking a decrease of 25.25.
• For Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 74.72 (Mar 24) to 0.00, marking a decrease of 74.72.
• For Cash Earning Retention Ratio (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 40. It has decreased from 74.75 (Mar 24) to 0.00, marking a decrease of 74.75.
• For Interest Coverage Ratio (X), as of Mar 25, the value is 68.84. This value is within the healthy range. It has decreased from 231.25 (Mar 24) to 68.84, marking a decrease of 162.41.
• For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 51.36. This value is within the healthy range. It has decreased from 170.84 (Mar 24) to 51.36, marking a decrease of 119.48.
• For Enterprise Value (Cr.), as of Mar 25, the value is 549.62. It has increased from 477.68 (Mar 24) to 549.62, marking an increase of 71.94.
• For EV / Net Operating Revenue (X), as of Mar 25, the value is 6.19. This value exceeds the healthy maximum of 3. It has decreased from 8.27 (Mar 24) to 6.19, marking a decrease of 2.08.
• For EV / EBITDA (X), as of Mar 25, the value is 31.98. This value exceeds the healthy maximum of 15. It has decreased from 52.43 (Mar 24) to 31.98, marking a decrease of 20.45.
• For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 6.17. This value exceeds the healthy maximum of 3. It has decreased from 8.30 (Mar 24) to 6.17, marking a decrease of 2.13.
• For Retention Ratios (%), as of Mar 25, the value is 0.00. This value is below the healthy minimum of 30. It has decreased from 74.71 (Mar 24) to 0.00, marking a decrease of 74.71.
• For Price / BV (X), as of Mar 25, the value is 5.06. This value exceeds the healthy maximum of 3. It has decreased from 5.61 (Mar 24) to 5.06, marking a decrease of 0.55.
• For Price / Net Operating Revenue (X), as of Mar 25, the value is 6.17. This value exceeds the healthy maximum of 3. It has decreased from 8.30 (Mar 24) to 6.17, marking a decrease of 2.13.
• For EarningsYield, as of Mar 25, the value is 0.02. This value is below the healthy minimum of 5. It has increased from 0.01 (Mar 24) to 0.02, marking an increase of 0.01.

Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.

Fair Value

*Investments are subject to market risks

Strength and Weakness